Net sales grew 17.6% year-over-year in Q2 2026, with strong RX segment growth and improved profitability. The company is investing in a new logistics centre to support long-term scalability and remains debt-free with a robust cash position.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.